Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 1
1999 1
2000 2
2001 5
2003 2
2004 1
2005 2
2006 1
2007 1
2010 1
2013 1
2015 1
2016 7
2017 8
2018 6
2019 9
2020 15
2021 16
2022 17
2023 18
2024 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Trained immunity in the pathogenesis of vitiligo.
Post NF, Ginski G, Peters R, Van Uden NOP, Bekkenk MW, Wolkerstorfer A, Netea MG, Luiten RM. Post NF, et al. Among authors: bekkenk mw. Pigment Cell Melanoma Res. 2023 Sep;36(5):348-354. doi: 10.1111/pcmr.13101. Epub 2023 Jun 9. Pigment Cell Melanoma Res. 2023. PMID: 37293969 Review.
The use of lasers in vitiligo, an overview.
Post NF, Ezekwe N, Narayan VS, Bekkenk MW, Van Geel N, Hamzavi I, Passeron T, Wolkerstorfer A. Post NF, et al. Among authors: bekkenk mw. J Eur Acad Dermatol Venereol. 2022 Jun;36(6):779-789. doi: 10.1111/jdv.18005. Epub 2022 Mar 1. J Eur Acad Dermatol Venereol. 2022. PMID: 35176186 Free PMC article. Review.
Targeting the PD-1/PD-L1 Axis in Human Vitiligo.
Willemsen M, Melief CJM, Bekkenk MW, Luiten RM. Willemsen M, et al. Among authors: bekkenk mw. Front Immunol. 2020 Nov 6;11:579022. doi: 10.3389/fimmu.2020.579022. eCollection 2020. Front Immunol. 2020. PMID: 33240267 Free PMC article. Review.
NB-UVB phototherapy response of different body regions in non-segmental vitiligo.
Narayan VS, Alagha E, Ouwerkerk W, Uitentuis SE, Lommerts JE, Esmat S, Mogawer RM, Ragab N, Chuah SY, Thng S, Wolkerstorfer A, Luiten RM, Bekkenk MW. Narayan VS, et al. Among authors: bekkenk mw. J Eur Acad Dermatol Venereol. 2023 Jun;37(6):e782-e785. doi: 10.1111/jdv.18946. Epub 2023 Feb 14. J Eur Acad Dermatol Venereol. 2023. PMID: 36734628 No abstract available.
Treatment recommendations for patients with vitiligo during COVID-19.
Rodrigues M, Pandya AG, Hamzavi I, Ezzedine K, Bekkenk MW, Harris JE. Rodrigues M, et al. Among authors: bekkenk mw. Australas J Dermatol. 2021 Aug;62(3):e481-e482. doi: 10.1111/ajd.13610. Epub 2021 May 24. Australas J Dermatol. 2021. PMID: 34028796 Free PMC article. No abstract available.
Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy.
Stalman EW, Wieske L, Keijser JBD, van Dam KPJ, Kummer LYL, Wilbrink MF, van Kempen ZLE, Killestein J, Volkers AG, Tas SW, Boekel L, Wolbink GJ, van der Kooi AJ, Raaphorst J, Löwenberg M, Takkenberg RB, D'Haens GRAM, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Hilhorst ML, Vegting Y, Bemelman FJ, Voskuyl AE, Broens B, Parra Sanchez A, van Els CACM, de Wit J, Rutgers A, de Leeuw K, Horváth B, Verschuuren JJGM, Ruiter AM, van Ouwerkerk L, van der Woude D, Allaart RCF, Onno Teng YK, van Paassen P, Busch MH, Brusse E, van Doorn PA, Baars AE, Hijnen D, Schreurs CRG, van der Pol WL, Goedee HS, Steenhuis M, Keijzer S, Cristianawati O, Brinke AT, Verstegen NJM, Zwinderman KAH, van Ham SM, Rispens T, Welkers MR, Jonges M, Eftimov F, Kuijpers TW; T2B! immunity against SARS-CoV-2 study group. Stalman EW, et al. Among authors: bekkenk mw. J Allergy Clin Immunol. 2024 Sep;154(3):754-766.e7. doi: 10.1016/j.jaci.2024.04.031. Epub 2024 May 17. J Allergy Clin Immunol. 2024. PMID: 38763170 Free article.
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination.
Valk AM, Keijser JBD, van Dam KPJ, Stalman EW, Wieske L, Steenhuis M, Kummer LYL, Spuls PI, Bekkenk MW, Musters AH, Post NF, Bosma AL, Horváth B, Hijnen DJ, Schreurs CRG, van Kempen ZLE, Killestein J, Volkers AG, Tas SW, Boekel L, Wolbink GJ, Keijzer S, Derksen NIL, van Deelen M, van Mierlo G, Kuijpers TW, Eftimov F, van Ham SM, Ten Brinke A, Rispens T; T2B! Immunity against SARS‐CoV‐2 study group. Valk AM, et al. Among authors: bekkenk mw. Allergy. 2024 Jul;79(7):1952-1961. doi: 10.1111/all.16089. Epub 2024 Mar 4. Allergy. 2024. PMID: 38439527
106 results